Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

G1 Therapeutics Inc (NQ: GTHX )

20.83 USD +0.16 (+0.77%)
Official Closing Price Updated: 5:48 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about G1 Therapeutics Inc

< Previous 1 2 3 4 Next >
G1 Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021
From GlobeNewswire News Releases
G1 Therapeutics Announces Appointment of William C. Roberts as Vice President, Investor Relations & Corporate Communications
From GlobeNewswire News Releases
G1 Therapeutics Presents Final Phase 2 Clinical Data on Trilaciclib in Combination with Chemotherapy in Metastatic Triple-Negative Breast Cancer Demonstrating Significant Improvement in Overall Surviv
Company also presents updated monotherapy data on investigational oral selective estrogen receptor degrader (SERD) rintodestrant for ER+, HER2- breast cancer 
From GlobeNewswire News Releases
Thinking about trading options or stock in Tesla, G1 Therapeutics, Apple, Micron Technology, or At Home Group?
InvestorsObserver issues critical PriceWatch Alerts for TSLA, GTHX, AAPL, MU, and HOME. 
From PR Newswire
G1 Therapeutics to Participate in the Evercore ISI 3rd Annual HealthCONx Conference on December 3, 2020
From GlobeNewswire News Releases
G1 Therapeutics to Present Clinical Data on Trilaciclib and Rintodestrant at 2020 San Antonio Breast Cancer Symposium (SABCS)
From GlobeNewswire News Releases
G1 Therapeutics to Present at the Stifel Virtual Healthcare Conference on November 18, 2020
From GlobeNewswire News Releases
G1 Therapeutics Provides Third Quarter 2020 Corporate and Financial Update
From GlobeNewswire News Releases
G1 Therapeutics to Provide Third Quarter 2020 Corporate and Financial Update on November 4, 2020
From GlobeNewswire News Releases
G1 Therapeutics to Present Data on Trilaciclib at North America Conference on Lung Cancer (NACLC)
From GlobeNewswire News Releases
G1 Therapeutics Announces Chief Executive Officer Succession Plan
From GlobeNewswire News Releases
G1 Therapeutics to Present Data on Oral CDK4/6 Inhibitor Lerociclib at European Society for Medical Oncology (ESMO) Virtual 2020 Congress
From GlobeNewswire News Releases
G1 Therapeutics to Participate in Four Investor Conferences in September 2020
From GlobeNewswire News Releases
G1 Therapeutics Announces Acceptance and Priority Review of NDA for Trilaciclib for Patients with Small Cell Lung Cancer
From GlobeNewswire News Releases
G1 Therapeutics Provides Second Quarter 2020 Corporate and Financial Update
From GlobeNewswire News Releases
G1 Therapeutics to Participate in BTIG and Wedbush Healthcare Conferences in August 2020
From GlobeNewswire News Releases
G1 Therapeutics and Simcere Announce Exclusive License Agreement for Trilaciclib in Greater China
From GlobeNewswire News Releases
G1 Therapeutics to Provide Second Quarter 2020 Corporate and Financial Update on August 5, 2020
From GlobeNewswire News Releases
G1 Therapeutics Announces License Agreement for Lerociclib
From GlobeNewswire News Releases
G1 Therapeutics and Boehringer Ingelheim Announce Co-Promotion Agreement for Trilaciclib in Small Cell Lung Cancer in the United States and Puerto Rico
From GlobeNewswire News Releases
G1 Therapeutics and Genor Biopharma Announce Exclusive License Agreement for Lerociclib in Asia-Pacific Region
From GlobeNewswire News Releases
G1 Therapeutics to Present Data Showing Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer at the ASCO20 Virtual Scientific Program
From GlobeNewswire News Releases
G1 Therapeutics Provides First Quarter 2020 Corporate and Financial Update
From GlobeNewswire News Releases
G1 Therapeutics to Provide First Quarter 2020 Corporate and Financial Update on May 6, 2020
From GlobeNewswire News Releases
G1 Therapeutics to Present at 19th Annual Needham Virtual Healthcare Conference on April 14, 2020
From GlobeNewswire News Releases
G1 Therapeutics Announces Appointment of New Board Member and Chief Commercial Officer
From GlobeNewswire News Releases
G1 Therapeutics Provides Fourth Quarter and Full-Year 2019 Corporate and Financial Update
From GlobeNewswire News Releases
G1 Therapeutics to Present at Investor Conferences in March 2020
From GlobeNewswire News Releases
G1 Therapeutics to Provide Fourth Quarter and Full Year 2019 Corporate and Financial Update on February 26, 2020
From GlobeNewswire News Releases
G1 Therapeutics to Participate in BTIG Targeted Therapeutics Conference on February 24, 2020
From GlobeNewswire News Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.